| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥3.33B | ¥2.91B | +14.4% |
| Cost of Sales | ¥2.32B | ¥1.92B | +20.9% |
| Gross Profit | ¥1.01B | ¥991M | +1.6% |
| SG&A Expenses | ¥913M | ¥943M | -3.2% |
| Operating Income | ¥94M | ¥47M | +100.0% |
| Non-operating Income | ¥91M | ¥31M | +193.3% |
| Non-operating Expenses | ¥20M | ¥11M | +75.1% |
| Ordinary Income | ¥165M | ¥67M | +146.3% |
| Profit Before Tax | ¥164M | ¥59M | +179.5% |
| Income Tax Expense | ¥55M | ¥57M | -4.7% |
| Net Income | ¥110M | ¥1M | +7683.2% |
| Net Income Attributable to Owners | ¥90M | ¥-17M | +629.4% |
| Total Comprehensive Income | ¥137M | ¥-2M | +6950.0% |
| Depreciation & Amortization | ¥15M | ¥13M | +14.1% |
| Interest Expense | ¥7M | ¥6M | +15.8% |
| Basic EPS | ¥9.92 | ¥-1.89 | +624.9% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥3.44B | ¥2.96B | +¥484M |
| Cash and Deposits | ¥1.94B | ¥1.46B | +¥488M |
| Accounts Receivable | ¥971M | ¥944M | +¥27M |
| Inventories | ¥267M | ¥319M | ¥-52M |
| Non-current Assets | ¥1.12B | ¥1.12B | ¥-4M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥248M | ¥-56M | +¥303M |
| Investing Cash Flow | ¥11M | ¥-23M | +¥35M |
| Financing Cash Flow | ¥193M | ¥-21M | +¥214M |
| Free Cash Flow | ¥259M | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 2.7% |
| Gross Profit Margin | 30.2% |
| Current Ratio | 156.8% |
| Quick Ratio | 144.6% |
| Debt-to-Equity Ratio | 1.26x |
| Interest Coverage Ratio | 13.69x |
| EBITDA Margin | 3.3% |
| Effective Tax Rate | 33.3% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +14.4% |
| Operating Income YoY Change | +98.0% |
| Ordinary Income YoY Change | +145.5% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 10.77M shares |
| Treasury Stock | 1.53M shares |
| Average Shares Outstanding | 9.13M shares |
| Book Value Per Share | ¥217.80 |
| EBITDA | ¥109M |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥3.00 |
| Segment | Revenue | Operating Income |
|---|---|---|
| Mediaplatform | ¥484M | ¥235M |
| MedicalBToB | ¥79M | ¥11M |
| MedicalInstitutionManagementSupport | ¥2.55B | ¥54M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥6.40B |
| Operating Income Forecast | ¥270M |
| Ordinary Income Forecast | ¥233M |
| Net Income Attributable to Owners Forecast | ¥121M |
| Basic EPS Forecast | ¥13.15 |
| Dividend Per Share Forecast | ¥3.00 |
| Property, Plant & Equipment | ¥132M | ¥133M | ¥-1M |
| Intangible Assets | ¥437M | ¥428M | +¥9M |
| Goodwill | ¥400M | ¥394M | +¥5M |
| Investment Securities | ¥56M | ¥56M | ¥0 |
| Total Assets | ¥4.56B | ¥4.08B | +¥480M |
| Current Liabilities | ¥2.20B | ¥1.93B | +¥264M |
| Accounts Payable | ¥482M | ¥409M | +¥73M |
| Short-term Loans | ¥951M | ¥846M | +¥105M |
| Non-current Liabilities | ¥350M | ¥380M | ¥-31M |
| Long-term Loans | ¥302M | ¥336M | ¥-34M |
| Total Liabilities | ¥2.55B | ¥2.31B | +¥234M |
| Total Equity | ¥2.01B | ¥1.77B | +¥246M |
| Capital Stock | ¥286M | ¥286M | ¥0 |
| Capital Surplus | ¥349M | ¥337M | +¥12M |
| Retained Earnings | ¥1.66B | ¥1.60B | +¥64M |
| Treasury Stock | ¥-400M | ¥-544M | +¥143M |
| Owners' Equity | ¥1.95B | ¥1.72B | +¥233M |
| Working Capital | ¥1.25B | - | - |